Tanaka, Y., Iwaya, C., Kawanami, T., Hamaguchi, Y., Horikawa, T., Shigeoka, T., Yanase, T., Kawanami, D., & Nomiyama, T
A dinner out on day four feels completely different from a dinner out on day one, much like the first week on semaglutide feels dramatically different from week four
Clinical trial data shows GERD symptoms occur in approximately 1.71.8% of patients taking Wegovy, while dyspepsia (including heartburn) affects 2.33.2% of patients
That study enrolled 3,417 adults with obesity or overweight and without type 2 diabetes, and showed a mean weight loss of 22.7% at 68 weeks in patients who remained on treatment
While it provides numerous benefits, healthcare providers must weigh its advantages against potential risks, especially when used for weight loss
Non-alcoholic fatty liver disease: cause or effect of metabolic syndrome